|Conditional recommendation based on low-quality evidence; may consider switching to another OSM# if the patient prefers an oral medication over an injection, or if the patient has contraindications to TNFi biologics, including congestive heart failure, previous serious infections, recurrent infections, or demyelinating disease.| |
|11. Switch to an IL-17i biologic over an IL-12/23i biologic (PICO 54)|Low (89, 90, 92, 93, 98â€“100)|
|---|---|